Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer

被引:47
作者
Dong, Wenjie
Chen, Xiaobing [2 ]
Xie, Jing [3 ]
Sun, Pinghu
Wu, Yunlin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Gastroenterol, Shanghai 200025, Peoples R China
[2] Henan Tumor Hosp, Dept Med Oncol, Zhengzhou, Peoples R China
[3] Shanghai Jiao Tong Univ, Dept Pathol, Rui Jin Hosp, Shanghai 200025, Peoples R China
关键词
gastric cancer; methylation; HAI-2/SPINT2; HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; RENAL-CELL CARCINOMA; HUMAN BREAST-CANCER; C-MET; OVARIAN-CANCER; PROTEASE INHIBITOR; BIKUNIN HAI-2/PB; MOUSE MODEL; EXPRESSION;
D O I
10.1002/ijc.25161
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocyte growth factor (HGF) activator inhibitor type 2 (HAI-2/SPINT2) encodes Kunitz-type protease inhibitor that regulates HGF activity. Inspection of the human HAI-2/SPINT2 locus uncovered a large and dense CpG island within the 5' region of this gene. Analysis of cultured human gastric tumor lines indicated that HAI-2/SPINT2 expression is either undetectable or in low abundance in several lines; however, enhanced gene expression was measured in cells cultured on the DNA demethylating agent 5-aza-2'-deoxycytidine. Bisulfite DNA sequencing confirmed the densely methylated HAI-2/SPINT2 promoter region. Forced expression of HAI-2/SPINT2 induced cell apoptosis, suppressed anchorage independent growth in vitro and tumor growth in vivo. We investigated HAI-2/SPINT2 aberrant methylation in patients with gastric cancer. The HAI-2/SPINT2 methylation was found preferentially in cancerous tissues (30 of 40, 75%) compared with nontumor tissues (no methylation was detected), indicating that this aberrant characteristic is common in gastric malignancies. In conclusion, epigenetic inactivation of HAI-2/SPINT2 is a common event contributing to gastric carcinogenesis and may be a potential biomarker for gastric cancer.
引用
收藏
页码:1526 / 1534
页数:9
相关论文
共 50 条
[41]   Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53 [J].
Malkomes, Patrizia ;
Lunger, Ilaria ;
Oppermann, Elsie ;
Abou-El-Ardat, Khalil ;
Oellerich, Thomas ;
Guenther, Stefan ;
Canbulat, Can ;
Bothur, Sabrina ;
Schnuetgen, Frank ;
Yu, Weijia ;
Wingert, Susanne ;
Haetscher, Nadine ;
Catapano, Claudia ;
Dietz, Marina S. ;
Heilemann, Mike ;
Kvasnicka, Hans-Michael ;
Holzer, Katharina ;
Serve, Hubert ;
Bechstein, Wolf Otto ;
Rieger, Michael A. .
ONCOGENE, 2021, 40 (25) :4352-4367
[42]   MiR-4500 is epigenetically downregulated in colorectal cancer and functions as a novel tumor suppressor by regulating HMGA2 [J].
Yu, Feng Yan ;
Tu, Yun ;
Deng, Ying ;
Guo, Cancan ;
Ning, Jue ;
Zhu, Yuzhen ;
Lv, Xiaohua ;
Ye, Hua .
CANCER BIOLOGY & THERAPY, 2016, 17 (11) :1149-1157
[43]   MicroRNA-144 functions as a tumor suppressor in gastric cancer by targeting cyclooxygenase-2 [J].
Yao, Qiang ;
Gu, Anxin ;
Wang, Zhuozhong ;
Xue, Yingwei .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (03) :3088-3095
[44]   KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome [J].
Ma, Gaoxiang ;
Liu, Hanting ;
Hua, Qiuhan ;
Wang, Meilin ;
Du, Mulong ;
Lin, Yadi ;
Ge, Yuqiu ;
Gong, Weida ;
Zhao, Qinghong ;
Qiang, Fulin ;
Tao, Guoquan ;
Zhang, Zhengdong ;
Chu, Haiyan .
MOLECULAR CANCER, 2017, 16
[45]   Inactivation of COX-2, HMLH1 and CDKN2A Gene by Promoter Methylation in Gastric Cancer: Relationship with Histological Subtype, Tumor Location and Helicobacter pylori Genotype [J].
Santos Alves, Markenia Kelia ;
Ferrasi, Adriana Camargo ;
Lima, Valeska Portela ;
Pitombeira Ferreira, Marcia Valeria ;
de Moura Campos Pardini, Maria Ines ;
Barem Rabenhorst, Silvia Helena .
PATHOBIOLOGY, 2011, 78 (05) :266-276
[46]   Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients [J].
X Li ;
K F Cheung ;
X Ma ;
L Tian ;
J Zhao ;
M Y Y Go ;
B Shen ;
A S L Cheng ;
J Ying ;
Q Tao ;
J J Y Sung ;
H-f Kung ;
J Yu .
Oncogene, 2012, 31 :3419-3430
[47]   Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer [J].
Shen, Ruizhe ;
Pan, Shen ;
Qi, Shengjian ;
Lin, Xiaolin ;
Cheng, Shidan .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 394 (04) :1047-1052
[48]   15-Hydroxyprostaglandin Dehydrogenase is Downregulated and Exhibits Tumor Suppressor Activity in Gastric Cancer [J].
Song, Ho June ;
Myung, Seung-Jae ;
Kim, In-Wha ;
Jeong, Jin-Yong ;
Park, Young Soo ;
Lee, Sun Mi ;
Nam, Won Hee ;
Ryu, Yeon-Mi ;
Fink, Stephen P. ;
Yang, Dong-Hoon ;
Jung, Hwoon-Yong ;
Kim, Jin-Ho .
CANCER INVESTIGATION, 2011, 29 (04) :257-265
[49]   Tyk2 is a tumor suppressor in colorectal cancer [J].
Moritsch, Stefan ;
Moedl, Bernadette ;
Scharf, Irene ;
Janker, Lukas ;
Zwolanek, Daniela ;
Timelthaler, Gerald ;
Casanova, Emilio ;
Sibilia, Maria ;
Mohr, Thomas ;
Kenner, Lukas ;
Herndler-Brandstetter, Dietmar ;
Gerner, Christopher ;
Mueller, Mathias ;
Strobl, Birgit ;
Eferl, Robert .
ONCOIMMUNOLOGY, 2022, 11 (01)
[50]   ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer [J].
Kunderfranco, Paolo ;
Mello-Grand, Maurizia ;
Cangemi, Romina ;
Pellini, Stefania ;
Mensah, Afua ;
Albertini, Veronica ;
Malek, Anastasia ;
Chiorino, Giovanna ;
Catapano, Carlo V. ;
Carbone, Giuseppina M. .
PLOS ONE, 2010, 5 (05)